HCV Next March Issue - Patient Reported Outcomes Critical in the Fight Against HCV

"HCV Next" offers information on a range of topics, which include diagnosis, new combination therapies, side effects, drug/drug interaction, guidelines, practice management issues, to name a few.

The following articles appeared in the March print edition of HCV NEXT, provided online at Healio.

Table of Contents

The Big Picture
Patient Reported Outcomes Critical in the Fight Against HCV

When patients are cured, they live longer and feel better. They will have less complications of advanced liver disease and their work productivity improves, which could potentially reduce the economic impact of HCV infection.

HCV Drug Spending Drops in 2016; Diabetes, Inflammatory Condition Spending Rising

5 Questions
A Conversation With Ashwani K. Singal, MD, MS, FACG

Cover Story
Telemedicine Programs Flourish in the DAA Era

Editorial
Insecurity Breeds Hysteria; Health Care Needs Evidence-Based Activism
Nancy S. Reau, MD, FAASLD, AGAF

Become Informed; Become Involved

In the Journals
Grazoprevir/Elbasvir Effectively Induces SVR in HCV with Prior Failure

Interventions Boost HCV Testing in Baby Boomers

BMJ: Trump’s Policies Risk ‘Head-on Collision’ with Science, Health Care

HCV Eradication in HIV Coinfected Patients Linked to Reduced Diabetes, Chronic Renal Failure

Zobair M. Younossi, MD, MPH

The Take Home
Conference on Retroviruses and Opportunistic Infections

March issue of HCV Next

http://www.healio.com/hepatology/news/print/hcv-next